Cookie Settings

AniCura safeguards antibiotics

Press release

AniCura, one of Europe’s leading providers of high-quality veterinary care for companion animals, continues the important task of fighting antimicrobial resistance through improving antibiotic use and infection control. For the second year in a row, AniCura has conducted an internal survey covering antibiotics use per type of diagnosis. The survey is a part of AniCura’s long term efforts in continuously improving veterinary medical quality.

QualiCura, AniCura’s systematic veterinary medical quality improvement program, was launched in 2015 with the aim to improve patient safety and achieve better medical outcomes. This covers that pets admitted to AniCura animal hospitals and clinics should receive treatment and care according to latest evidence and that spread of micro-organisms to the patients should be minimized. Within the QualiCura program, antibiotic use and consumption of hand sanitizers are monitored, with the latter being an indirect measurement of hand hygiene. Results from surveys are together with best practice guidelines communicated to hospitals and clinics within AniCura.

– It has been a tremendously stimulating year to work with QualiCura. Many of our hospitals and clinics want to safeguard antibiotics and have increased their preventive work against antimicrobial resistance. More hand sanitizers have been installed and several many of AniCura’s veterinarians have limited their prescription of antibiotics for certain conditions with good medical outcomes, says Ulrika Grönlund, Group Medical Quality Manager at AniCura.

Antibiotics are life-saving drugs but from a patient safety perspective it can also pose a danger if given for the wrong indication. The danger is that antibiotics disturb the patient’s normal microflora and that resistant bacteria will grow in numbers. This means that longer term efficacy of antibiotics will be impaired. In addition, antimicrobial resistant bacteria can spread to pet owners and for that reason, AniCura from a societal perspective is taking a large responsibility for wiser overall antibiotic use.

For the second year in a row, AniCura performed a diagnosis-prescription study in dogs in October. In total, data from 200 cases and from 65 animal hospitals and clinics in Sweden, Norway, Denmark, Germany, Austria, Switzerland and the Netherlands was gathered. Preliminary results show that wound infection is the most common indication for antibiotic treatment and that beta-lactam antibiotics are the most frequently used class.

– It is encouraging that also this year’s survey shows that we use a very small amount of antibiotics classified as critically important (CIA) by WHO, despite the fact that more countries participated in the survey this year, says Ulrika Grönlund.

More specific results from this year’s survey together with suggested improvements will be communicated to AniCura’s hospitals and clinics. In addition, AniCura provides courses in antibiotic use, infection control and wound treatment as a part of the company’s ambition to safeguard antibiotics and improve patient safety.

For further information, please contact

Ulrika Grönlund, Group Medical Quality Manager at AniCura, +46 706 387 562, ulrika.gronlund@anicuragroup.com